BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24722127)

  • 1. Sleep quality in patients with primary aldosteronism.
    Hanusch FM; Fischer E; Lang K; Diederich S; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M
    Hormones (Athens); 2014; 13(1):57-64. PubMed ID: 24722127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep disturbances in primary aldosteronism are associated to depressive symptoms - Could specific mineralocorticoidreceptors be a common pathway?
    Adolf C; Murck H; Sarkis AL; Schneider H; Fischer I; Steiger A; Braun LT; Reincke M; Künzel H
    J Psychiatr Res; 2024 Apr; 172():66-70. PubMed ID: 38367319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism.
    Fourkiotis V; Vonend O; Diederich S; Fischer E; Lang K; Endres S; Beuschlein F; Willenberg HS; Rump LC; Allolio B; Reincke M; Quinkler M;
    Eur J Endocrinol; 2013 Jan; 168(1):75-81. PubMed ID: 23033260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of Life in Primary Aldosteronism: A Comparative Effectiveness Study of Adrenalectomy and Medical Treatment.
    Velema M; Dekkers T; Hermus A; Timmers H; Lenders J; Groenewoud H; Schultze Kool L; Langenhuijsen J; Prejbisz A; van der Wilt GJ; Deinum J;
    J Clin Endocrinol Metab; 2018 Jan; 103(1):16-24. PubMed ID: 29099925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea.
    Wang E; Chomsky-Higgins K; Chen Y; Nwaogu I; Seib CD; Shen WT; Duh QY; Suh I
    J Surg Res; 2019 Apr; 236():37-43. PubMed ID: 30694777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.
    Künzel HE; Apostolopoulou K; Pallauf A; Gerum S; Merkle K; Schulz S; Fischer E; Brand V; Bidlingmaier M; Endres S; Beuschlein F; Reincke M
    J Psychiatr Res; 2012 Dec; 46(12):1650-4. PubMed ID: 23017810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worsening of lipid metabolism after successful treatment of primary aldosteronism.
    Adolf C; Asbach E; Dietz AS; Lang K; Hahner S; Quinkler M; Rump LC; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Reincke M
    Endocrine; 2016 Oct; 54(1):198-205. PubMed ID: 27179655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression.
    Engler L; Heinrich DA; Adolf C; Riester A; Franke A; Pawlowski M; Beuschlein F; Reincke M; Steiger A; Künzel H
    J Psychiatr Res; 2019 May; 112():52-60. PubMed ID: 30852427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea.
    Wolley MJ; Pimenta E; Calhoun D; Gordon RD; Cowley D; Stowasser M
    J Hum Hypertens; 2017 Sep; 31(9):561-567. PubMed ID: 28382959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases.
    Iwakura Y; Morimoto R; Kudo M; Ono Y; Takase K; Seiji K; Arai Y; Nakamura Y; Sasano H; Ito S; Satoh F
    J Clin Endocrinol Metab; 2014 May; 99(5):1593-8. PubMed ID: 24285678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.
    Weigel M; Riester A; Hanslik G; Lang K; Willenberg HS; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M
    Eur J Endocrinol; 2015 Apr; 172(4):443-50. PubMed ID: 25630564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism.
    Sukor N; Kogovsek C; Gordon RD; Robson D; Stowasser M
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1360-4. PubMed ID: 20089615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
    Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort.
    Worth PJ; Kunio NR; Siegfried I; Sheppard BC; Gilbert EW
    Am J Surg; 2015 Oct; 210(4):702-9. PubMed ID: 26323999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperkalemia in both surgically and medically treated patients with primary aldosteronism.
    Wada N; Shibayama Y; Umakoshi H; Ichijo T; Fujii Y; Kamemura K; Kai T; Sakamoto R; Ogo A; Matsuda Y; Fukuoka T; Tsuiki M; Suzuki T; Naruse M
    J Hum Hypertens; 2017 Oct; 31(10):627-632. PubMed ID: 28540931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of unilateral adrenalectomy on the quality of life of patients with lateralized primary aldosteronism.
    Citton M; Viel G; Torresan F; Rossi GP; Iacobone M
    BMC Surg; 2019 Apr; 18(Suppl 1):105. PubMed ID: 31074381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life in primary aldosteronism: A prospective observational study.
    Buffolo F; Cavaglià G; Burrello J; Amongero M; Tetti M; Pecori A; Sconfienza E; Veglio F; Mulatero P; Monticone S
    Eur J Clin Invest; 2021 Mar; 51(3):e13419. PubMed ID: 32997795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience.
    Sukor N; Gordon RD; Ku YK; Jones M; Stowasser M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2437-45. PubMed ID: 19401369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.
    Haase M; Riester A; Kröpil P; Hahner S; Degenhart C; Willenberg HS; Reincke M
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4397-402. PubMed ID: 25222758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms predict the quality of sleep in patients with partial epilepsy--A combined retrospective and prospective study.
    Moser D; Pablik E; Aull-Watschinger S; Pataraia E; Wöber C; Seidel S
    Epilepsy Behav; 2015 Jun; 47():104-10. PubMed ID: 25982882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.